eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hyperuricemia |
| Comorbidity | C0022658|kidney disease |
| Sentences | 18 |
| PubMedID- 26297226 | In the multivariable cox proportional hazard analyses after adjustment for several confounding factors including chronic kidney disease and use of diuretics, hyperuricemia was an independent predictor of all-cause mortality (hazard ratio 1.98, 95% confidence interval 1.036-3.793, p = 0.039). |
| PubMedID- 21303423 | Management of asymptomatic hyperuricaemia in patients with chronic kidney disease by japanese nephrologists: a questionnaire survey. |
| PubMedID- 24152124 | Febuxostat for treating allopurinol-resistant hyperuricemia in patients with chronic kidney disease. |
| PubMedID- 26414732 | hyperuricemia is associated with hypertension, kidney disease, vascular and cardiovascular (cv) events. |
| PubMedID- 21547469 | hyperuricemia is associated with chronic kidney disease, arterial hypertension, coronary artery and heart disease, cerebrovascular disease and diabetes mellitus. |
| PubMedID- 21694941 | Other factors that may contribute to the relatively low rate of hyperuricemia and gout in patients with chronic kidney disease (ckd) include lower protein intake and increased intestinal clearance of uric acid. |
| PubMedID- 23506426 | Acute neutropenia associated with initiation of febuxostat therapy for hyperuricaemia in patients with chronic kidney disease. |
| PubMedID- 25210423 | Febuxostat for hyperuricemia in patients with advanced chronic kidney disease. |
| PubMedID- 21722384 | Background: hyperuricemia is prevalent in patients with chronic kidney disease (ckd). |
| PubMedID- 23621557 | Objectives: in this article, the results of clinical and experimental studies that examine the association of hyperuricemia and gout with hypertension and kidney disease are presented and discussed. |
| PubMedID- 21783292 | Background: hyperuricemia is common in patients with chronic kidney disease (ckd). |
| PubMedID- 24877124 | However, the pathologic role of hyperuricemia in kidney disease by a crystal-independent mechanism is somewhat less clear. |
| PubMedID- 25685556 | Although hyperuricemia is common in patients with chronic kidney disease, the impact of uric acid on mortality and cv events remains unclear. |
| PubMedID- 24433285 | Methods/design: the feather (febuxostat versus placebo randomized controlled trial regarding reduced renal function in patients with hyperuricemia complicated by chronic kidney disease stage 3) study is a prospective, multicenter, double-blind, randomized, placebo-controlled trial of febuxostat-a novel, nonpurine, selective, xanthine oxidase inhibitor. |
| PubMedID- 24612195 | Rhabdomyolysis associated with initiation of febuxostat therapy for hyperuricaemia in a patient with chronic kidney disease. |
| PubMedID- 22948067 | Gender difference in the association of hyperuricemia with chronic kidney disease in southern china. |
| PubMedID- 23960345 | This is a retrospective cohort study in chronic kidney disease (ckd) patients with hyperuricemia from 1998 to 2008. |
| PubMedID- 23058478 | Recent observational studies have associated hyperuricemia with kidney disease. |
Page: 1